Selected research
Market Outlook & Growth Opportunities
Global AI Therapy Chatbots Market Outlook and Growth Opportunities 2026
Market perspective
The global AI Therapy Chatbots market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for AI Therapy Chatbots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Therapy Chatbots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Therapy Chatbots is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the AI Therapy Chatbots market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the AI Therapy Chatbots market include MIT(Eliza), Pear Therapeutics, Woebot Health, Expresso, Wysa, X2AI, Huma, Youper and Replika, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global AI Therapy Chatbots market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Therapy Chatbots and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Therapy Chatbots revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Therapy Chatbots market.
AI Therapy Chatbots Segment by Company
MIT(Eliza)
Pear Therapeutics
Woebot Health
Expresso
Wysa
X2AI
Huma
Youper
Replika
Mindstrong Health
Marigold Health
Miyourobot
Xinchenai
Ai-beings
Leading-ai
Pku
Lx-tech
Csjbot
AI Therapy Chatbots Segment by Type
Rogerian Psychotherapy
Cognitive Behavior Therapy
AI Therapy Chatbots Segment by Application
To C
To B
To G
Others
AI Therapy Chatbots Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global AI Therapy Chatbots status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the AI Therapy Chatbots key companies, revenue, market share, and recent developments.
3. To split the AI Therapy Chatbots breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions AI Therapy Chatbots market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify AI Therapy Chatbots significant trends, drivers, influence factors in global and regions.
6. To analyze AI Therapy Chatbots competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Therapy Chatbots market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Therapy Chatbots and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Therapy Chatbots.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Therapy Chatbots industry.
Chapter 3: Detailed analysis of AI Therapy Chatbots company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of AI Therapy Chatbots in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of AI Therapy Chatbots in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Rogerian Psychotherapy
- Cognitive Behavior Therapy
Applications
- To C
- To B
- To G
- Others
Companies covered
- MIT(Eliza)
- Pear Therapeutics
- Woebot Health
- Expresso
- Wysa
- X2AI
- Huma
- Youper
- Replika
- Mindstrong Health
- Marigold Health
- Miyourobot
- Xinchenai
- Ai-beings
- Leading-ai
- Pku
- Lx-tech
- Csjbot
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global AI Therapy Chatbots Market Size, 2021 VS 2025 VS 2032
- 1.3 Global AI Therapy Chatbots Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 AI Therapy Chatbots Market Dynamics
- 2.1 AI Therapy Chatbots Industry Trends
- 2.2 AI Therapy Chatbots Industry Drivers
- 2.3 AI Therapy Chatbots Industry Opportunities and Challenges
- 2.4 AI Therapy Chatbots Industry Restraints
3 AI Therapy Chatbots Market by Company
- 3.1 Global AI Therapy Chatbots Company Revenue Ranking in 2025
- 3.2 Global AI Therapy Chatbots Revenue by Company (2021-2026)
- 3.3 Global AI Therapy Chatbots Company Ranking (2024-2026)
- 3.4 Global AI Therapy Chatbots Company Manufacturing Base and Headquarters
- 3.5 Global AI Therapy Chatbots Company Product Type and Application
- 3.6 Global AI Therapy Chatbots Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global AI Therapy Chatbots Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 AI Therapy Chatbots Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 AI Therapy Chatbots Market by Type
- 4.1 AI Therapy Chatbots Type Introduction
- 4.1.1 Rogerian Psychotherapy
- 4.1.2 Cognitive Behavior Therapy
- 4.2 Global AI Therapy Chatbots Sales Value by Type
- 4.2.1 Global AI Therapy Chatbots Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global AI Therapy Chatbots Sales Value by Type (2021-2032)
- 4.2.3 Global AI Therapy Chatbots Sales Value Share by Type (2021-2032)
5 AI Therapy Chatbots Market by Application
- 5.1 AI Therapy Chatbots Application Introduction
- 5.1.1 To C
- 5.1.2 To B
- 5.1.3 To G
- 5.1.4 Others
- 5.2 Global AI Therapy Chatbots Sales Value by Application
- 5.2.1 Global AI Therapy Chatbots Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global AI Therapy Chatbots Sales Value by Application (2021-2032)
- 5.2.3 Global AI Therapy Chatbots Sales Value Share by Application (2021-2032)
6 AI Therapy Chatbots Regional Value Analysis
- 6.1 Global AI Therapy Chatbots Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global AI Therapy Chatbots Sales Value by Region (2021-2032)
- 6.2.1 Global AI Therapy Chatbots Sales Value by Region: 2021-2026
- 6.2.2 Global AI Therapy Chatbots Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America AI Therapy Chatbots Sales Value (2021-2032)
- 6.3.2 North America AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe AI Therapy Chatbots Sales Value (2021-2032)
- 6.4.2 Europe AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific AI Therapy Chatbots Sales Value (2021-2032)
- 6.5.2 Asia-Pacific AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America AI Therapy Chatbots Sales Value (2021-2032)
- 6.6.2 South America AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa AI Therapy Chatbots Sales Value (2021-2032)
- 6.7.2 Middle East & Africa AI Therapy Chatbots Sales Value Share by Country, 2025 VS 2032
7 AI Therapy Chatbots Country-level Value Analysis
- 7.1 Global AI Therapy Chatbots Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global AI Therapy Chatbots Sales Value by Country (2021-2032)
- 7.2.1 Global AI Therapy Chatbots Sales Value by Country (2021-2026)
- 7.2.2 Global AI Therapy Chatbots Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.3.2 USA AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.7.2 France AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.14.2 China AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.17.2 India AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt AI Therapy Chatbots Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt AI Therapy Chatbots Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt AI Therapy Chatbots Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 MIT(Eliza)
- 8.1.1 MIT(Eliza) Company Information
- 8.1.2 MIT(Eliza) Business Overview
- 8.1.3 MIT(Eliza) AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.1.4 MIT(Eliza) AI Therapy Chatbots Product Portfolio
- 8.1.5 MIT(Eliza) Recent Developments
- 8.2 Pear Therapeutics
- 8.2.1 Pear Therapeutics Company Information
- 8.2.2 Pear Therapeutics Business Overview
- 8.2.3 Pear Therapeutics AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.2.4 Pear Therapeutics AI Therapy Chatbots Product Portfolio
- 8.2.5 Pear Therapeutics Recent Developments
- 8.3 Woebot Health
- 8.3.1 Woebot Health Company Information
- 8.3.2 Woebot Health Business Overview
- 8.3.3 Woebot Health AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.3.4 Woebot Health AI Therapy Chatbots Product Portfolio
- 8.3.5 Woebot Health Recent Developments
- 8.4 Expresso
- 8.4.1 Expresso Company Information
- 8.4.2 Expresso Business Overview
- 8.4.3 Expresso AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.4.4 Expresso AI Therapy Chatbots Product Portfolio
- 8.4.5 Expresso Recent Developments
- 8.5 Wysa
- 8.5.1 Wysa Company Information
- 8.5.2 Wysa Business Overview
- 8.5.3 Wysa AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.5.4 Wysa AI Therapy Chatbots Product Portfolio
- 8.5.5 Wysa Recent Developments
- 8.6 X2AI
- 8.6.1 X2AI Company Information
- 8.6.2 X2AI Business Overview
- 8.6.3 X2AI AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.6.4 X2AI AI Therapy Chatbots Product Portfolio
- 8.6.5 X2AI Recent Developments
- 8.7 Huma
- 8.7.1 Huma Company Information
- 8.7.2 Huma Business Overview
- 8.7.3 Huma AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.7.4 Huma AI Therapy Chatbots Product Portfolio
- 8.7.5 Huma Recent Developments
- 8.8 Youper
- 8.8.1 Youper Company Information
- 8.8.2 Youper Business Overview
- 8.8.3 Youper AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.8.4 Youper AI Therapy Chatbots Product Portfolio
- 8.8.5 Youper Recent Developments
- 8.9 Replika
- 8.9.1 Replika Company Information
- 8.9.2 Replika Business Overview
- 8.9.3 Replika AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.9.4 Replika AI Therapy Chatbots Product Portfolio
- 8.9.5 Replika Recent Developments
- 8.10 Mindstrong Health
- 8.10.1 Mindstrong Health Company Information
- 8.10.2 Mindstrong Health Business Overview
- 8.10.3 Mindstrong Health AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.10.4 Mindstrong Health AI Therapy Chatbots Product Portfolio
- 8.10.5 Mindstrong Health Recent Developments
- 8.11 Marigold Health
- 8.11.1 Marigold Health Company Information
- 8.11.2 Marigold Health Business Overview
- 8.11.3 Marigold Health AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.11.4 Marigold Health AI Therapy Chatbots Product Portfolio
- 8.11.5 Marigold Health Recent Developments
- 8.12 Miyourobot
- 8.12.1 Miyourobot Company Information
- 8.12.2 Miyourobot Business Overview
- 8.12.3 Miyourobot AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.12.4 Miyourobot AI Therapy Chatbots Product Portfolio
- 8.12.5 Miyourobot Recent Developments
- 8.13 Xinchenai
- 8.13.1 Xinchenai Company Information
- 8.13.2 Xinchenai Business Overview
- 8.13.3 Xinchenai AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.13.4 Xinchenai AI Therapy Chatbots Product Portfolio
- 8.13.5 Xinchenai Recent Developments
- 8.14 Ai-beings
- 8.14.1 Ai-beings Company Information
- 8.14.2 Ai-beings Business Overview
- 8.14.3 Ai-beings AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.14.4 Ai-beings AI Therapy Chatbots Product Portfolio
- 8.14.5 Ai-beings Recent Developments
- 8.15 Leading-ai
- 8.15.1 Leading-ai Company Information
- 8.15.2 Leading-ai Business Overview
- 8.15.3 Leading-ai AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.15.4 Leading-ai AI Therapy Chatbots Product Portfolio
- 8.15.5 Leading-ai Recent Developments
- 8.16 Pku
- 8.16.1 Pku Company Information
- 8.16.2 Pku Business Overview
- 8.16.3 Pku AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.16.4 Pku AI Therapy Chatbots Product Portfolio
- 8.16.5 Pku Recent Developments
- 8.17 Lx-tech
- 8.17.1 Lx-tech Company Information
- 8.17.2 Lx-tech Business Overview
- 8.17.3 Lx-tech AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.17.4 Lx-tech AI Therapy Chatbots Product Portfolio
- 8.17.5 Lx-tech Recent Developments
- 8.18 Csjbot
- 8.18.1 Csjbot Company Information
- 8.18.2 Csjbot Business Overview
- 8.18.3 Csjbot AI Therapy Chatbots Revenue and Gross Margin (2021-2026)
- 8.18.4 Csjbot AI Therapy Chatbots Product Portfolio
- 8.18.5 Csjbot Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst